Comparative penetration of various cephalosporins into inflammatory exudate.

Antimicrobial Agents and Chemotherapy
I C Guerrero, R R MacGregor

Abstract

A rabbit sterile peritonitis model was used to determine the relative penetration of four cephalosporin antibiotics into exudate fluid. Male New Zealand white rabbits were given 120 ml of sterile saline intraperitoneally, and peritonitis developed over the following 8 h, with exudate fluid containing a mean of 17,188 granulocytes per mm(3) at 8 h. Each antibiotic was administered intramuscularly at a dose of 30 mg/kg 3 h after peritonitis was initiated, and serum and peritoneal concentrations were measured 0.5, 1, 2, and 4 h later. Cefamandole gave the highest mean peak serum level (26.8 mug/ml), and cephalothin, cephacetrile, and cephradine all gave peak serum levels between 13 and 15 mug/ml. When peak peritoneal exudate concentration was expressed as a percentage of peak serum concentration, cephradine developed 28.5% of the peak serum level, cephacetrile 27.7%, cephalothin 14.0%, and cefamandole 12.5%. These percentages of exudate penetration were inversely proportional to the degree of serum protein binding: cephradine 26.6%, cephacetrile 36.3%, cephalothin 50%, and cefamandole 88%.

References

Aug 1, 1978·Antimicrobial Agents and Chemotherapy·D N GerdingE A Schierl
Apr 1, 1977·Antimicrobial Agents and Chemotherapy·C CarbonS Lamotte-Barrillon
Dec 1, 1977·Antimicrobial Agents and Chemotherapy·M G BergeronL Gauvreau
Nov 1, 1976·Antimicrobial Agents and Chemotherapy·D N GerdingW H Hall
Dec 1, 1976·Antimicrobial Agents and Chemotherapy·D N GerdingR E Manion
Nov 1, 1972·The Journal of Infectious Diseases·J S TanC Watanakunakorn
Mar 1, 1974·Antimicrobial Agents and Chemotherapy·N WatermanM J Raff
Mar 1, 1966·Applied Microbiology·J V BennettW M Kirby
Dec 1, 1971·The Journal of Infectious Diseases·T SmithivasJ J Rahal
Aug 1, 1974·Antimicrobial Agents and Chemotherapy·H C Neu

❮ Previous
Next ❯

Citations

Jan 1, 1982·European Journal of Clinical Pharmacology·H H Thijssen, J Wolters
Dec 1, 1989·Journal of Veterinary Pharmacology and Therapeutics·C R Clarke
Oct 1, 1987·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology·N Frimodt-MøllerV F Thomsen
Oct 1, 1983·Antimicrobial Agents and Chemotherapy·T A LarsonL R Peterson

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.